Literature DB >> 11401475

WISP-2: a serum-inducible gene differentially expressed in human normal breast epithelial cells and in MCF-7 breast tumor cells.

M N Zoubine1, S Banerjee, N K Saxena, D R Campbell, S K Banerjee.   

Abstract

WISP-2 is a Wnt-1-induced signaling protein identified as a member of CCN growth factor family. A role for this molecule during tumorigenesis is suspected but remains unproven. Here we show that WISP-2 expression was undetectable, or minimally detectable, in nontransformed human mammary epithelial cells, but was overexpressed in MCF-7 cells. Expression of WISP-2 in MCF-7 cells was modulated by serum and correlated with the serum-induced MCF-7 tumor cell proliferation, suggesting that WISP-2 is serum responsive and may be a positive regulator of tumor cell proliferation. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11401475     DOI: 10.1006/bbrc.2001.4584

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  CCN5: biology and pathophysiology.

Authors:  Joshua W Russo; John J Castellot
Journal:  J Cell Commun Signal       Date:  2010-09-21       Impact factor: 5.782

2.  Differential expression of WISP-1 and WISP-2 genes in normal and transformed human breast cell lines.

Authors:  N Saxena; S Banerjee; K Sengupta; M N Zoubine; S K Banerjee
Journal:  Mol Cell Biochem       Date:  2001-12       Impact factor: 3.396

3.  CCN5/WISP-2: A micromanager of breast cancer progression.

Authors:  Sushanta K Banerjee; Snigdha Banerjee
Journal:  J Cell Commun Signal       Date:  2012-04-10       Impact factor: 5.782

4.  2-Methoxyestradiol exhibits a biphasic effect on VEGF-A in tumor cells and upregulation is mediated through ER-alpha: a possible signaling pathway associated with the impact of 2-ME2 on proliferative cells.

Authors:  Samarendra N Banerjee; Krishanu Sengupta; Snigdha Banerjee; Neela K Saxena; Sushanta K Banerjee
Journal:  Neoplasia       Date:  2003 Sep-Oct       Impact factor: 5.715

5.  Role of WISP-2/CCN5 in the maintenance of a differentiated and noninvasive phenotype in human breast cancer cells.

Authors:  Asmaà Fritah; Cécile Saucier; Olivier De Wever; Marc Bracke; Ivan Bièche; Rosette Lidereau; Christian Gespach; Sylvain Drouot; Gérard Redeuilh; Michèle Sabbah
Journal:  Mol Cell Biol       Date:  2007-12-10       Impact factor: 4.272

6.  WISP-2 gene in human breast cancer: estrogen and progesterone inducible expression and regulation of tumor cell proliferation.

Authors:  Snigdha Banerjee; Neela Saxena; Krishanu Sengupta; Ossama Tawfik; Matthew S Mayo; Sushanta K Banerjee
Journal:  Neoplasia       Date:  2003 Jan-Feb       Impact factor: 5.715

7.  CCN5 is a growth arrest-specific gene that regulates smooth muscle cell proliferation and motility.

Authors:  Andrew C Lake; Ann Bialik; Kenneth Walsh; John J Castellot
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

8.  WISP-2 in human gastric cancer and its potential metastatic suppressor role in gastric cancer cells mediated by JNK and PLC-γ pathways.

Authors:  Jiafu Ji; Shuqin Jia; Yongning Jia; Ke Ji; Rachel Hargest; Wen G Jiang
Journal:  Br J Cancer       Date:  2015-08-20       Impact factor: 7.640

9.  Domain-and species-specific monoclonal antibodies recognize the Von Willebrand Factor-C domain of CCN5.

Authors:  Lan Wei; Frank McKeon; Joshua W Russo; Joan Lemire; John Castellot
Journal:  J Cell Commun Signal       Date:  2009-04-29       Impact factor: 5.782

10.  Loss of WISP2/CCN5 in estrogen-dependent MCF7 human breast cancer cells promotes a stem-like cell phenotype.

Authors:  Nathalie Ferrand; Anne Gnanapragasam; Guillaume Dorothee; Gérard Redeuilh; Annette K Larsen; Michèle Sabbah
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.